Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma CellsSean A. Misek, Richard R. Neubig|Molecular Pharmacology|2021Cited by 16
Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activityJason J. Kwon, Andrew J. Aguirre, Yuemin Bian et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 9